Recovery of BCS Class II drugs during aqueous redispersion of core-shell type nanocomposite particles produced via fluidized bed coating

Powder Technology

Volumn 236, Issue , 2013, Pages 221-234

  Bhakay, Anagha ^a   Davé, Rajesh ^a   Bilgili, Ecevit ^a  

^a NEW JERSEY INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Core shell type nanocomposite microparticles; Drug nanoparticles; Fluidized bed coating; Redispersion; Wet media milling

Indexed keywords

DRUG NANO PARTICLES; FLUIDIZED BED COATING; NANOCOMPOSITE MICROPARTICLES; REDISPERSIONS; WET-MEDIA MILLINGS;

BIOCHEMISTRY; COATINGS; DISSOLUTION; DRUG DOSAGE; FLUIDIZED BEDS; MILLING (MACHINING); NANOCOMPOSITES; PARTICLE SIZE ANALYSIS; RECOVERY; SODIUM DODECYL SULFATE; SURFACE ACTIVE AGENTS;

NANOPARTICLES;

DODECYL SULFATE SODIUM; GRISEOFULVIN; HYDROXYPROPYLCELLULOSE; NANOPARTICLE; PHENYLBUTAZONE; SURFACTANT; WATER;

ARTICLE; DISPERSION; DRUG COATING; DRUG FORMULATION; DRUG SOLUBILITY; FLUIDIZED BED; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY;

EID: 84873723515     PISSN: 00325910     EISSN: 1873328X     Source Type: Journal    
DOI: 10.1016/j.powtec.2011.12.066     Document Type: Article

References (55)

1. Muller R., Peters K. Nanosuspensions for the formulation of poorly soluble drugs: I. Preparation by a size reduction technique. International Journal of Pharmaceutics 1998, 160:229-237.
2. Noyes A., Whitney W. The rate of solution of solid substances in their own solutions. Journal of the American Chemical Society 1897, 19:930-934.
3. Bilgili E., Hamey R., Scarlett B. Production of pigment nanoparticles using a wet stirred media mill with polymeric media. China Particuology 2004, 2:93-100.
4. Bilgili E., Hamey R., Scarlett B. Nano-milling of pigment agglomerates using a wet stirred media mill: elucidation of the kinetics and breakage mechanisms. Chemical Engineering Science 2006, 61:149-157.
5. Akkar A., Namsolleck P., Blaut M., Muller R. Solubilizing poorly soluble antimycotic agents by emulsification via a solvent-free process. AAPS PharmSciTech 2004, 5:1-6.
6. Vogt M., Kunath K., Dressman J. Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: comparison with commercial preparations. European Journal of Pharmaceutics and Biopharmaceutics 2008, 68:283-288.
7. Dalvi S., Dave R. Analysis of nucleation kinetics of poorly water-soluble drugs in presence of ultrasound and hydroxypropyl methyl cellulose during antisolvent precipitation. International Journal of Pharmaceutics 2010, 387:172-179.
8. Hashem M., Shaker D., Ghorab M., Nasr M., Ismail A. Formulation, characterization, and clinical evaluation of microemulsion containing clotrimazole for topical delivery. AAPS PharmSciTech 2011, 10.1208/s12249-011-9653-7.
9. G. Liversidge, K. Cundy, J. Bishop, D. Czekai, Surface modified drug nanoparticles, US Patent, US5145684.
10. Israelachvili J. Intermolecular and Surface Forces 1992, Academic Press, New York. 2nd ed.
11. Lee J. Drug nano- and microparticles processed into solid dosage forms: physical properties. Journal of Pharmaceutical Sciences 2003, 92:2057-2068.
12. Van Eerdenbrugh B., Froyen L., Humbeeck J., Martens J., Augustijns P., Mooter G. Drying of crystalline drug nanosuspensions - the importance of surface hydrophobicity on dissolution behavior upon redispersion. European Journal of Pharmaceutical Sciences 2008, 35:127-135.
13. Van Eerdenbrugh B., Froyen L., Humbeeck J., Martens J., Augustijns P., Mooter G. Alternative matrix formers for nanosuspension solidification: dissolution performance and X-ray microanalysis as an evaluation tool for powder dispersion. European Journal of Pharmaceutical Sciences 2008, 35:344-353.
14. Tewa-Tagne P., Briancon S., Fessi H. Preparation of redispersible dry nanocapsules by means of spray-drying: development and characterization. European Journal of Pharmaceutical Sciences 2007, 30:124-135.
15. Hu J., Ng W., Dong Y., Shen S., Tan R. Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray drying. International Journal of Pharmaceutics 2011, 404:198-204.
16. Chaubal M., Popescu C. Conversion of nanosuspensions into dry powders by spray drying: a case study. Pharmaceutical Research 2008, 25:2302-2308.
17. Kho K., Cheow W., Lie R., Hadinoto K. Aqueous re-dispersibility of spray-dried antibiotic-loaded polycaprolactone nanoparticle aggregates for inhaled anti-biofilm therapy. Powder Technology 2010, 203:432-439.
18. Vogt M., Vertzoni M., Kunath K., Reppas C., Dressman J. Cogrinding enhances the oral bioavailability of EMD 57033, a poorly water soluble drug, in dogs. European Journal of Pharmaceutics and Biopharmaceutics 2008, 68:338-345.
19. Li C., Li C., Le Y., Chen J. Formation of bicalutamide nanodispersion for dissolution rate enhancement. International Journal of Pharmaceutics 2011, 404:257-263.
20. Biradar S., Patil A., Sudarsan G., Pokharkar V. A comparative study of approaches used to improve solubility of roxithromycin. Powder Technology 2006, 169:22-32.
21. Cheow W., Ng M., Kho K., Hadinoto K. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants. International Journal of Pharmaceutics 2011, 404:289-300.
22. Konan Y., Gurny R., Allemann E. Preparation and characterization of sterile and freeze-dried sub-200nm nanoparticles. International Journal of Pharmaceutics 2002, 233:239-252.
23. Abdelwahed W., Degobert G., Fessi H. Investigation of nanocapsules stabilization by amorphous excipients during freeze drying and storage. European Journal of Pharmaceutics and Biopharmaceutics 2006, 63:87-94.
24. Layre A., Couvreur P., Richard J., Requier D., Ghermani N., Gref R. Freeze-drying of composite core-shell nanoparticles. Drug Development and Industrial Pharmacy 2006, 32:839-846.
25. Schwarz C., Mehnert W. Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN). International Journal of Pharmaceutics 1997, 157:171-179.
26. Waard H., Hinrichs W., Frijlink A. A novel bottom-up process to produce drug nanocrystals: controlled crystallization during freeze-drying. Journal of Controlled Release 2008, 128:179-183.
27. Dong Y., Ng W., Shen S., Kima S., Tan R. Controlled antisolvent precipitation of spirinolactone nanoparticles by impingement mixing. International Journal of Pharmaceutics 2011, 410:175-179.
28. Li W., Yang Y., Xu X., Chen Y., Mu L., Zhang Y., Fang L. Preparation and in vitro/in vivo evaluation of revaprazan hydrochloride nanosuspension. International Journal of Pharmaceutics 2011, 408:157-162.
29. Van Eerdenbrugh B., Froyen L., Martens J., Blaton N., Augustijns P., Brewster M., Mooter G. Charaterization of physico-chemical properties and pharmaceutical performance of sucrose co-freeze dried solid nanoparticulate powders of the anti-HIV agent loviride prepared by media milling. International Journal of Pharmaceutics 2007, 338:198-206.
30. Kim S., Lee J. Effective polymeric dispersants for vacuum, convection and freeze drying of drug nanosuspensions. International Journal of Pharmaceutics 2010, 397:218-224.
31. Choi J., Park C., Lee J. Effect of polymer molecular weight on nanocomminution of poorly soluble drug. Drug Delivery 2008, 15:347-353.
32. Basa S., Muniyappan T., Karatgi P., Prabhu R., Pillai R. Production and in vitro characterization of solid dosage form incorporating drug nanoparticles. Drug Development and Industrial Pharmacy 2008, 34:1209-1218.
33. N. Ryde, S. Ruddy, Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate, (2002) US Patent 6375986.
34. Moschwitzer J., Muller R. Spray coated pellets as carrier system for mucoadhesive drug nanocrystals. European Journal of Pharmaceutics and Biopharmaceutics 2006, 62:282-287.
35. A. Stamm, P. Seth, Fenofibrate pharmaceutical compositions having high bioavailability and method for preparing it, (2000) US Patent 6074670.
36. Eskin D., Zhupanska O., Hamey R., Moudgil B., Scarlett B. Microhydrodynamics of stirred media milling. Powder Technology 2005, 156:95-102.
37. Bhakay A., Merwade M., Bilgili E., Dave R. Novel aspects of wet milling for the production of microsuspensions and nanosuspensions of poorly water soluble drugs. Drug Development and Industrial Pharmacy 2011, 37:963-976.
38. Chen Y., Yang J., Mujumdar A., Dave R. Fluidized bed film coating of cohesive Geldart group C powders. Powder Technology 2009, 189:466-480.
39. Rasenack N., Hartenhauer H., Muller B. Microcrystals for dissolution rate enhancement of poorly water-soluble drugs. International Journal of Pharmaceutics 2003, 254:137-145.
40. Van Eerdenbrugh B., Vermant J., Martens J., Froyen L., Van Humbeeck J., Augustijns P., Mooter G. A screening study of surface stabilization during the production of drug nanocrystals. Journal of Pharmaceutical Sciences 2009, 98:2091-2103.
41. Hecq J., Nollevaux G., Deleers M., Fanara D., Vranckx H., Peulen O., Dandrifosse G., Amighi K. Nifedipine nanocrystals: pharmacokinetic evaluation in the rat and permeability studies in Caco-2/HT29-5M21 (co)-cultures. Journal of Drug Delivery Science and Technology 2006, 16:437-442.
42. Jeong Y., Shim Y., Kim C., Lim G., Choi K., Yoon C. Effect of cryoprotectants on the reconstitution of surfactant-free nanoparticles of poly(DL-lactide-co-glycolide). Journal of Microencapsulation 2005, 22:593-601.
43. Kesisoglou F., Panmai S., Wu Y. Nanosizing - oral formulation development and biopharmaceutical evaluation. Advanced Drug Delivery Reviews 2007, 59:631-644.
44. Suzuki M., Machida M., Adachi K., Otabe K., Sugimoto T., Hayashi M., Awazu S. Histopathological study of the effects of a single intratracheal instillation of surface active agents on lung in rats. The Journal of Toxicological Sciences 2000, 25:49-55.
45. Lebhardt T., Roesler S., Uusitalo H., Kissel T. Surfactant-free redispersible nanoparticles in fast-dissolving composite microcarriers for dry-powder inhalation. European Journal of Pharmaceutics and Biopharmaceutics 2011, 78:90-96.
46. Petrovic L., Sovilj V., Katona J., Milanovic J. Influence of polymer-surfactant interactions on o/w emulsion properties and microcapsule formation. Journal of Colloid and Interface Science 2010, 342:333-339.
47. Kho K., Hadinoto K. Effects of excipient formulation on the morphology and aqueous re-dispersibility of dry-powder silica nano-aggregates. Colloids and Surfaces A: Physicochemical and Engineering Aspects 2010, 359:71-81.
48. Timpe C. Drug solubilization strategies applying nanoparticulate formulation and solid dispersion approaches in drug development. American Pharmaceutical Review 2010, 13:12-21.
49. 2. Powder Technology 2009, 196:36-49.
50. 2 nanoparticles into redispersible granules. Powder Technology 2010, 203:384-388.
51. Kusters K., Pratsinis S., Thoma S., Smith D. Ultrasonic fragmentation of agglomerate powders. Chemical Engineering Science 1993, 48:4119-4127.
52. Ding P., Pacek A. De-agglomeration of goethite nano-particles using ultrasonic comminution device. Powder Technology 2008, 187:1-10.
53. Pacek A., Ding P., Utomo A. Effect of energy density, pH and temperature on de-aggregation in nano-particles/water suspensions in high shear mixer. Powder Technology 2007, 173:203-210.
54. Matteucci M., Paguio J., Miller M., Williams R., Johnston K. Flocculated amorphous nanoparticles for highly saturated solutions. Pharmaceutical Research 2008, 25:2477-2487.
55. De Villiers M. Influence of agglomeration of cohesive particles on the dissolution behavior of furosemide powder. International Journal of Pharmaceutics 1996, 136:175-179.